Skip to main content
[Preprint]. 2024 Feb 15:2024.02.14.580225. [Version 1] doi: 10.1101/2024.02.14.580225
Patients’ characteristics classified
by Severity of COVID-19
(n=147)
Severity 5 (SYMP)
(Patients died)
(n = 26)
Severity 4 (SYMP)
(ICU + vent.)
(n = 15)
Severity 3 (SYMP)
(ICU)
(n = 21)
Severity 2 (SYMP)
(Inpatients, Reg. Adm.)
(n = 64)
Severity 1 (SYMP)
(ED)
(n = 12)
Severity 0
(ASYMP)
(n = 9)
Demographic features Age median 65 (39-90) 52 (33-85) 53 (26-86) 57 (23-85) 51 (27-91) 27 (19-51)
Gender (Male/Female) 19/7 (73%/27%) 9/6 (60%/40%) 13/8 (62%/38%) 37/27 (58%/42%) 5/7 (42%/58%) 5/4 (56%/44%)
Race (% White/non-White) 6/20 (23%/77%) 8/7 (53%/47%) 13/8 (62%/38%) 25/39 (39%/61%) 7/5 (58%/42%) 2/7 (29%/71%)
Class I & II HLA status
HLA-A*0201+ 13 (50%) 8 (53%) 12 (57%) 24 (38%) 7 (58%) 7 (78%)
HLA-DRB1*01:01+ 14 (54%) 11 (73%) 12 (57%) 41 (64%) 7 (58%) 7 (78%)
Clinical parameters
(4.8 days average for all 147 patients)
Days between onset of symptoms and blood draw (mean) 5.9 5.7 4.6 4.5 4.1 -
Fever (>38°C) 21 (81%) 11 (73%) 10 (48%) 30 (47%) 4 (33%) 0 (0%)
Cough 23 (88%) 13 (87%) 16 (76%) 22 (34%) 4 (33%) 0 (0%)
Shortness of Breath/Dyspnea 28 (100%) 15 (100%) 6 (29%) 11 (17%) 1 (8%) 0 (0%)
Fatigue/Myalgia 9 (35%) 5 (33%) 6 (29%) 3 (5%) 3 (25%) 0 (0%)
Headache 5 (19%) 1 (%) 4 (19%) 12 (19%) 4 (33%) 0 (0%)
Nausea 3 (12%) 3 (20%) 3 (14%) 3 (5%) 0 (0%) 0 (0%)
Diarrhea 7 (27%) 2 (13%) 2 (10%) 8 (13%) 0 (0%) 0 (0%)
Anosmia/Ageusia 6 (23%) 4 (27%) 6 (29%) 17 (27%) 1 (8%) 0 (0%)
Sore Throat 4 (15%) 1 (7%) 1 (5%) 3 (5%) 1 (8%) 0 (0%)
ICU Admission 26 (100%) 15 (100%) 21 (100%) 0 (0%) 0 (0%) 0 (0%)
Ventilator Support 26 (100%) 15 (100%) 0 (0%) 0 (0% 0 (0%) 0 (0%)
White Blood Cells – (count: 103 cells /μL of blood) (average) 14.3 10.8 10.1 8.4 6.2 8.0
Lymphocytes – (103 cells /μL of blood and %) (average) 0.7 (6%) 0.9 (10%) 1.0 (13%) 1.4 (16%) 1.6 (27%) 2.4 (29.3%)
Comorbidities
Average number of all comorbidities 3.5 2.9 2.8 1.9 1.6 0.7
Diabetes 14 (54%) 9 (60%) 13 (62%) 29 (45%) 4 (33%) 0 (0%)
Hypertension (HTN) 16 (62%) 6 (40%) 9 (43%) 18 (28%) 4 (33%) 1 (11%)
Cardiovascular disease (CVD) 17 (65%) 6 (40%) 6 (29%) 13 (20%) 3 (25%) 0 (0%)
Coronary Artery disease (CAD) 12 (46%) 5 (33%) 7 (33%) 12 (19%) 2 (17%) 0 (0%)
Kidney diseases (CKD/ESRD) 7 (27%) 4 (27%) 6 (29%) 7 (11%) 1 (8%) 0 (0%)
Asthma/COPD 9 (35%) 1 (7%) 3 (14%) 12 (19%) 0 (0%) 1 (11%)
Obesity 12 (46%) 12 (80%) 7 (33%) 29 (45%) 4 (33%) 4 (44%)
Cancer 4(15%) 0(0%) 2(10%) 6(9%) 1(8%) 0 (0%)